{"id":"https://openalex.org/W2000381333","doi":"https://doi.org/10.2217/17435889.2.2.219","title":"Doxorubicin-Loaded PLGA Nanoparticles by Nanoprecipitation: Preparation, Characterization and In Vitro Evaluation","display_name":"Doxorubicin-Loaded PLGA Nanoparticles by Nanoprecipitation: Preparation, Characterization and In Vitro Evaluation","publication_year":2007,"publication_date":"2007-03-23","ids":{"openalex":"https://openalex.org/W2000381333","doi":"https://doi.org/10.2217/17435889.2.2.219","mag":"2000381333","pmid":"https://pubmed.ncbi.nlm.nih.gov/17716122"},"language":"en","primary_location":{"id":"doi:10.2217/17435889.2.2.219","doi":"https://doi.org/10.2217/17435889.2.2.219","is_oa":false,"landing_page_url":"https://doi.org/10.2217/17435889.2.2.219","pdf_url":null,"source":{"id":"https://openalex.org/S4210216406","display_name":"Nanomedicine","issn_l":"1743-5889","issn":["1743-5889","1748-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000381333"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059795073","display_name":"Tania Betancourt","orcid":"https://orcid.org/0000-0002-2460-6133","observed_orcids":["https://orcid.org/0000-0002-2460-6133"]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tania Betancourt","raw_affiliation_strings":["Department of Biomedical Engineering, The University of Texas at Austin, 1 University Station, MC 0800, Austin, TX78712, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, The University of Texas at Austin, 1 University Station, MC 0800, Austin, TX78712, USA","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066017702","display_name":"Brandon S Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Brown","raw_affiliation_strings":["School of Biological Sciences, The University of Texas at Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biological Sciences, The University of Texas at Austin, TX, USA","institution_ids":["https://openalex.org/I86519309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000932052","display_name":"Lisa Brannon\u2010Peppas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I86519309","display_name":"The University of Texas at Austin","ror":"https://ror.org/00hj54h04","country_code":"US","type":"education","lineage":["https://openalex.org/I86519309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa Brannon-Peppas","raw_affiliation_strings":["Department of Biomedical Engineering, The University of Texas at Austin, 1 University Station, MC 0800, Austin, TX78712, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Engineering, The University of Texas at Austin, 1 University Station, MC 0800, Austin, TX78712, USA","institution_ids":["https://openalex.org/I86519309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I86519309"],"apc_list":null,"apc_paid":null,"fwci":4.6202,"has_fulltext":false,"cited_by_count":256,"citation_normalized_percentile":{"value":0.95573631,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"2","issue":"2","first_page":"219","last_page":"232"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11686","display_name":"Dendrimers and Hyperbranched Polymers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/plga-nanoparticles","display_name":"PLGA nanoparticles","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nanoprecipitation","display_name":"nanoprecipitation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/ph-responsive-drug-release","display_name":"pH-responsive drug release","score":0.824999988079071},{"id":"https://openalex.org/keywords/breast-cancer-cells","display_name":"breast cancer cells","score":0.7429999709129333},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.5590000152587891},{"id":"https://openalex.org/keywords/drug-loading","display_name":"drug loading","score":0.5},{"id":"https://openalex.org/keywords/nanoparticle-cytotoxicity","display_name":"nanoparticle cytotoxicity","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8369731903076172},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.7235298752784729},{"id":"https://openalex.org/C2780165375","wikidata":"https://www.wikidata.org/wiki/Q2102907","display_name":"PLGA","level":3,"score":0.7021065354347229},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.6174687147140503},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.5979194641113281},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5828583836555481},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5733310580253601},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5720273852348328},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.523708164691925},{"id":"https://openalex.org/C86807702","wikidata":"https://www.wikidata.org/wiki/Q2620381","display_name":"Bovine serum albumin","level":2,"score":0.4842626750469208},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.4785473942756653},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4664807915687561},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4664791226387024},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.4139360785484314},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.39915069937705994},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3019527196884155},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.28882288932800293},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.2205430269241333},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20263990759849548},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1272677183151245},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12458828091621399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0963144302368164},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001826","descriptor_name":"Body Fluids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004058","descriptor_name":"Diffusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005590","descriptor_name":"Fractional Precipitation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049329","descriptor_name":"Nanostructures","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D049329","descriptor_name":"Nanostructures","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2217/17435889.2.2.219","doi":"https://doi.org/10.2217/17435889.2.2.219","is_oa":false,"landing_page_url":"https://doi.org/10.2217/17435889.2.2.219","pdf_url":null,"source":{"id":"https://openalex.org/S4210216406","display_name":"Nanomedicine","issn_l":"1743-5889","issn":["1743-5889","1748-6963"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine","raw_type":"journal-article"},{"id":"pmid:17716122","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17716122","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nanomedicine (London, England)","raw_type":"Evaluation Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W24682425","https://openalex.org/W38411318","https://openalex.org/W103369661","https://openalex.org/W133637778","https://openalex.org/W175748349","https://openalex.org/W266691892","https://openalex.org/W593950929","https://openalex.org/W653019020","https://openalex.org/W1813850579","https://openalex.org/W1935630572","https://openalex.org/W1965067289","https://openalex.org/W1968396250","https://openalex.org/W1973230016","https://openalex.org/W1975519085","https://openalex.org/W1976621692","https://openalex.org/W1976638726","https://openalex.org/W1976677427","https://openalex.org/W1981745506","https://openalex.org/W1983934583","https://openalex.org/W1998396545","https://openalex.org/W2000307014","https://openalex.org/W2000910488","https://openalex.org/W2003764754","https://openalex.org/W2008615025","https://openalex.org/W2009049928","https://openalex.org/W2009749128","https://openalex.org/W2022645876","https://openalex.org/W2022981155","https://openalex.org/W2047368765","https://openalex.org/W2055483349","https://openalex.org/W2063453892","https://openalex.org/W2066202831","https://openalex.org/W2079473817","https://openalex.org/W2081385408","https://openalex.org/W2081950007","https://openalex.org/W2082865634","https://openalex.org/W2089773350","https://openalex.org/W2110651692","https://openalex.org/W2110688302","https://openalex.org/W2111901647","https://openalex.org/W2113282769","https://openalex.org/W2118844383","https://openalex.org/W2121496050","https://openalex.org/W2143629227","https://openalex.org/W2152222526","https://openalex.org/W2154043786","https://openalex.org/W2154794327","https://openalex.org/W2159905203","https://openalex.org/W2321692081","https://openalex.org/W2464924982","https://openalex.org/W2505104219","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7162954177","https://openalex.org/W2982426301","https://openalex.org/W2372737297","https://openalex.org/W6903996610","https://openalex.org/W2902460456","https://openalex.org/W2050181086","https://openalex.org/W2951982437","https://openalex.org/W3129407517","https://openalex.org/W2199589991","https://openalex.org/W2770439161"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,200],"lack":[2],"of":[3,5,29,38,53,108,113,121,136,193,211,214,240,248,264,277,289],"specificity":[4],"chemotherapeutic":[6,30,58],"agents":[7],"to":[8,13,25,129,151,170,177,185,206,234,270,273,284,296],"cancer":[9,90,299],"tissue":[10],"commonly":[11],"leads":[12],"dose-limiting":[14],"side":[15],"effects":[16],"and":[17,36,49,84,97,116,158,167,217,224,283],"poor":[18],"therapeutic":[19,174,255],"results.":[20],"Drug":[21],"delivery":[22],"systems":[23],"promise":[24],"improve":[26],"the":[27,34,39,46,57,79,153,178,191,215,222,225,241,246,275,290],"deficiencies":[28],"treatment":[31],"by":[32,72,262],"modifying":[33],"biodistribution":[35],"pharmacokinetics":[37],"drug":[40,59,119,154,223,242,291],"in":[41,50,159,165,172,245,253,257,279,292],"vivo.":[42],"Here,":[43],"we":[44],"report":[45],"preparation,":[47],"characterization":[48],"vitro":[51],"evaluation":[52],"a":[54,98,111,117,142,173,187,209,280],"carrier":[55],"for":[56,190],"doxorubicin":[60,198,278],"based":[61],"on":[62],"acid-capped":[63],"poly(lactic-co-glycolic":[64,266],"acid)":[65,267],"nanoparticles.":[66],"METHODS:":[67],"Doxorubicin-loaded":[68],"nanoparticles":[69,194,249],"were":[70,82,124,149,168,268],"prepared":[71],"nanoprecipitation":[73,263],"with":[74,87,94,104,195],"bovine":[75],"serum":[76],"albumin":[77],"as":[78],"stabilizer.":[80],"Nanoparticles":[81,148,260],"characterized":[83],"their":[85],"interaction":[86,220],"MDA-MB-231":[88,297],"breast":[89,298],"cells":[91,156],"was":[92,127,139,183],"examined":[93],"confocal":[95],"microscopy":[96],"toxicological":[99],"assay.":[100],"RESULTS:":[101],"Spherical":[102],"particles":[103],"an":[105,293],"average":[106],"diameter":[107],"230":[109],"nm,":[110],"zeta-potential":[112],"-45":[114],"mV":[115],"maximum":[118],"loading":[120],"5":[122],"wt%":[123],"prepared.":[125],"Doxorubicin":[126],"found":[128,150,169,184,269],"be":[130,186,208,271],"quickly":[131,157],"released":[132,140],"at":[133,141,145,227],"endolysosomal":[134],"pH":[135,146],"4.0":[137],"but":[138],"slower":[143],"rate":[144],"7.4.":[147],"deliver":[152,286],"into":[155],"higher":[160],"quantity":[161],"than":[162],"when":[163,243],"presented":[164],"solution":[166],"result":[171,210,252],"efficacy":[175,256],"comparable":[176],"free":[179],"drug.":[180],"DISCUSSION:":[181],"Nanoprecipitation":[182],"promising":[188],"method":[189],"preparation":[192],"relatively":[196],"high":[197,287],"loading.":[199],"pH-dependent":[201,281],"release":[202,276],"behavior":[203],"is":[204],"discussed":[205],"possibly":[207],"accelerated":[212],"degradation":[213],"polymer":[216,226],"decreasing":[218],"ionic":[219],"between":[221],"acidic":[228],"pH.":[229],"Additional":[230],"studies":[231],"are":[232],"needed":[233],"determine":[235],"why":[236],"increased":[237,254],"nuclear":[238],"localization":[239],"delivered":[244],"form":[247,295],"did":[250],"not":[251],"vitro.":[258],"CONCLUSION:":[259],"formulated":[261],"acid-ended":[265],"able":[272],"control":[274],"manner":[282],"effectively":[285],"payloads":[288],"active":[294],"cells.":[300]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":15},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
